RMD.AU

37.76

+0.35%↑

RMD.AU

37.76

+0.35%↑

RMD.AU

37.76

+0.35%↑

RMD.AU

37.76

+0.35%↑

RMD.AU

37.76

+0.35%↑

Search

HEALIUS LTD

Fermé

SecteurSoins de santé

0.88 -1.12

Résumé

Variation du prix de l'action

24h

Actuel

Min

0.88

Max

0.9

Chiffres clés

By Trading Economics

Revenu

-13M

Ventes

-14M

682M

Marge bénéficiaire

-1.933

Employés

3,699

EBITDA

-91M

85M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

-12.71% downside

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

91M

635M

Ouverture précédente

2

Clôture précédente

0.88

Sentiment de l'Actualité

By Acuity

36%

64%

131 / 374 Classement par Healthcare

HEALIUS LTD Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 nov. 2025, 18:59 UTC

Principaux Mouvements du Marché

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

17 nov. 2025, 23:40 UTC

Market Talk

Gold Consolidates Amid Mixed Signals -- Market Talk

17 nov. 2025, 23:34 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

17 nov. 2025, 22:58 UTC

Market Talk

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

17 nov. 2025, 22:46 UTC

Market Talk

Risk Assets Set to Have a Strong 2026 -- Market Talk

17 nov. 2025, 22:06 UTC

Acquisitions, Fusions, Rachats

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

17 nov. 2025, 22:02 UTC

Résultats

Trip.com Group 3Q Rev $2.6B >TCOM

17 nov. 2025, 22:02 UTC

Résultats

Trip.com Group 3Q Adj EPS $3.87 >TCOM

17 nov. 2025, 22:02 UTC

Résultats

Trip.com Group 3Q EPS $4.02 >TCOM

17 nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 nov. 2025, 21:40 UTC

Résultats

James Hardie Industries 2Q Adj EPS 26c >JHX

17 nov. 2025, 21:40 UTC

Résultats

James Hardie Industries 2Q Loss/Shr 10c >JHX

17 nov. 2025, 21:39 UTC

Résultats

James Hardie Industries 2Q Sales $1.29B >JHX

17 nov. 2025, 21:38 UTC

Résultats
Acquisitions, Fusions, Rachats

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 nov. 2025, 21:38 UTC

Résultats

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

17 nov. 2025, 21:10 UTC

Résultats

XP Inc. 3Q EPS BRL2.47 >XP

17 nov. 2025, 21:10 UTC

Résultats

XP Inc. 3Q Rev BRL4.67B >XP

17 nov. 2025, 20:20 UTC

Market Talk

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

17 nov. 2025, 20:12 UTC

Market Talk

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

17 nov. 2025, 20:12 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 nov. 2025, 20:09 UTC

Market Talk

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

17 nov. 2025, 19:29 UTC

Market Talk

Gold Slide Continues to Start Week -- Market Talk

17 nov. 2025, 19:16 UTC

Résultats
Acquisitions, Fusions, Rachats

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 nov. 2025, 18:20 UTC

Acquisitions, Fusions, Rachats

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

17 nov. 2025, 16:45 UTC

Acquisitions, Fusions, Rachats

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

17 nov. 2025, 16:16 UTC

Résultats
Acquisitions, Fusions, Rachats

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 nov. 2025, 16:15 UTC

Résultats

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

17 nov. 2025, 15:40 UTC

Acquisitions, Fusions, Rachats

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

17 nov. 2025, 15:22 UTC

Acquisitions, Fusions, Rachats

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

17 nov. 2025, 15:19 UTC

Market Talk

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

Comparaison

Variation de prix

HEALIUS LTD prévision

Objectif de Prix

By TipRanks

-12.71% baisse

Prévisions sur 12 Mois

Moyen 0.786 AUD  -12.71%

Haut 0.9 AUD

Bas 0.62 AUD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

0

Achat

6

Maintien

2

Vente

Sentiment

By Acuity

131 / 374Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos HEALIUS LTD

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics, QML Pathology, TML Pathology, Abbott Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories, medical centers, patient collection centers, and community imaging centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
help-icon Live chat